相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Surface charge, glycocalyx, and blood-brain barrier function
Fruzsina R. Walter et al.
TISSUE BARRIERS (2021)
Modified cyclodextrin-based nanoparticles mediated delivery of siRNA for huntingtin gene silencing across an in vitro BBB model
Monique C. P. Mendonca et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
Gene Therapy for Polyglutamine Spinocerebellar Ataxias: Advances, Challenges, and Perspectives
Yaimee Vazquez-Mojena et al.
MOVEMENT DISORDERS (2021)
Gene therapy for ALS: A review
Defne A. Amado et al.
MOLECULAR THERAPY (2021)
Tissue distribution and cellular localization of gold nanocarriers with bound oligonucleotides
Nayab Fatima et al.
NANOMEDICINE (2021)
Double setback for ASO trials in Huntington disease
Katie Kingwell
NATURE REVIEWS DRUG DISCOVERY (2021)
Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles
Jeremy P. Bost et al.
ACS NANO (2021)
Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNS
Tetsuya Nagata et al.
NATURE BIOTECHNOLOGY (2021)
Comparison of polypeptides that bind the transferrin receptor for targeting gold nanocarriers
Conor McQuaid et al.
PLOS ONE (2021)
Systemic Brain Delivery of Antisense Oligonucleotides across the Blood-Brain Barrier with a Glucose-Coated Polymeric Nanocarrier
Hyun Su Min et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Nanoparticle brain delivery: a guide to verification methods
Robert A. Yokel
NANOMEDICINE (2020)
MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma
Sakiko Yoshida et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
Enriched chitosan nanoparticles loaded with siRNA are effective in lowering Huntington's disease gene expression following intranasal administration
Vasyl Sava et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
William M. Pardridge
FRONTIERS IN AGING NEUROSCIENCE (2020)
Efficient Delivery of Antisense Oligonucleotides Using Bioreducible Lipid Nanoparticles In Vitro and In Vivo
Liu Yang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs
Saba Naqvi et al.
FRONTIERS IN NEUROSCIENCE (2020)
Advances in oligonucleotide drug delivery
Thomas C. Roberts et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
Tuo Wei et al.
NATURE COMMUNICATIONS (2020)
Gold nanocarriers for transport of oligonucleotides across brain endothelial cells
Nayab Fatima et al.
PLOS ONE (2020)
Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock
Raygene Martier et al.
FRONTIERS IN NEUROSCIENCE (2020)
Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics
Shahryar Shakeri et al.
BIOMEDICINES (2020)
Cannabidiol Enhances the Passage of Lipid Nanocapsules across the Blood-Brain Barrier Both in Vitro and in Vivo
Juan Aparicio-Blanco et al.
MOLECULAR PHARMACEUTICS (2019)
Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality
Eloise Hudry et al.
NEURON (2019)
Nanomaterials for Drug Delivery to the Central Nervous System
Daniel Mihai Teleanu et al.
NANOMATERIALS (2019)
Allele-specific silencing as treatment for gene duplication disorders: proof-of-principle in autosomal dominant leukodystrophy
Elisa Giorgio et al.
BRAIN (2019)
Lowering Mutant Huntingtin Using Tricyclo-DNA Antisense Oligonucleotides As a Therapeutic Approach for Huntington's Disease
Marine Imbert et al.
NUCLEIC ACID THERAPEUTICS (2019)
Gene Therapy Tools for Brain Diseases
Selene Ingusci et al.
FRONTIERS IN PHARMACOLOGY (2019)
Magnetic Nanoparticles in the Central Nervous System: Targeting Principles, Applications and Safety Issues
Federico D'Agata et al.
MOLECULES (2018)
Targeted Delivery of DNA-Au Nanoparticles across the Blood-Brain Barrier Using Focused Ultrasound
Tiffany G. Chan et al.
CHEMMEDCHEM (2018)
Locked nucleic acid: modality, diversity, and drug discovery
Peter H. Hagedorn et al.
DRUG DISCOVERY TODAY (2018)
Lipid coated chitosan-DNA nanoparticles for enhanced gene delivery
Elias Baghdan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Crossing the blood-brain barrier with nanoparticles
Yiqun Zhou et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Recent progress and considerations for AAV gene therapies targeting the central nervous system
Erik Allen Lykken et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2018)
Oligonucleotide therapeutics in neurodegenerative diseases
Daniel R. Scoles et al.
RNA BIOLOGY (2018)
PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies
Marcelle Silva-Abreu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Gene therapy for neurological disorders: progress and prospects
Benjamin E. Deverman et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques
Florie Borel et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Antisense oligonucleotides in neurological disorders
Claudia D. Wurster et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
Advances in spinal muscular atrophy therapeutics
Valeria Parente et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications
Wenzhang Cha et al.
MOLECULES (2017)
Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
Daniel R. Scoles et al.
NATURE (2017)
Oligonucleotide therapies for disorders of the nervous system
Olga Khorkova et al.
NATURE BIOTECHNOLOGY (2017)
The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy
Constantin d'Ydewalle et al.
NEURON (2017)
Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain
Y. Anraku et al.
NATURE COMMUNICATIONS (2017)
Improving the Delivery of SOD1 Antisense Oligonucleotides to Motor Neurons Using Calcium Phosphate-Lipid Nanoparticles
Liyu Chen et al.
FRONTIERS IN NEUROSCIENCE (2017)
Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
Lauren R. Moore et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
Kunwoo Lee et al.
NATURE BIOMEDICAL ENGINEERING (2017)
Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma
Kasper Bendix Johnsen et al.
SCIENTIFIC REPORTS (2017)
Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer's disease
Dongdong Sun et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Current status of non-viral gene therapy for CNS disorders
Rahul Dev Jayant et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system
Lindsey Crawford et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
Richard S. Finkel et al.
LANCET (2016)
Localization and mobility of glucose-coated gold nanoparticles within the brain
Radka Gromnicova et al.
NANOMEDICINE (2016)
The delivery of therapeutic oligonucleotides
Rudolph L. Juliano
NUCLEIC ACIDS RESEARCH (2016)
Antisense oligonucleotides in therapy for neurodegenerative disorders
Melvin M. Evers et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Spontaneous penetration of gold nanoparticles through the blood brain barrier (BBB)
Hagit Sela et al.
JOURNAL OF NANOBIOTECHNOLOGY (2015)
The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model
Malka Shilo et al.
JOURNAL OF NANOBIOTECHNOLOGY (2015)
Intraventricular Delivery of siRNA Nanoparticles to the Central Nervous System
Rishab Shyam et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Magnetic Nanoparticles Cross the Blood-Brain Barrier: When Physics Rises to a Challenge
Maria Antonia Busquets et al.
NANOMATERIALS (2015)
In Vitro and in Vivo Studies on the Transport of PEGylated Silica Nanoparticles across the Blood-Brain Barrier
Dan Liu et al.
ACS APPLIED MATERIALS & INTERFACES (2014)
Accessing Targeted Nanoparticles to the Brain: The Vascular Route
A. Burkhart et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Gold Nanoparticles for Nucleic Acid Delivery
Ya Ding et al.
MOLECULAR THERAPY (2014)
Transport of nanoparticles through the blood-brain barrier for imaging and therapeutic applications
Malka Shilo et al.
NANOSCALE (2014)
Nonsense-mediated decay as a terminating mechanism for antisense oligonucleotides
Amanda J. Ward et al.
NUCLEIC ACIDS RESEARCH (2014)
Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates
S. J. Gray et al.
GENE THERAPY (2013)
Liposomes and nanotechnology in drug development: focus on neurological targets
Pedro Ramos-Cabrer et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
Progress in gene therapy for neurological disorders
Michele Simonato et al.
NATURE REVIEWS NEUROLOGY (2013)
Glucose-Coated Gold Nanoparticles Transfer across Human Brain Endothelium and Enter Astrocytes In Vitro
Radka Gromnicova et al.
PLOS ONE (2013)
Angiopep-Conjugated Nanoparticles for Targeted Long-Term Gene Therapy of Parkinson's Disease
Rongqin Huang et al.
PHARMACEUTICAL RESEARCH (2013)
Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain
Ravi L. Rungta et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles
Meenakshi Malhotra et al.
JOURNAL OF PHARMACEUTICS (2013)
Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
Holly B. Kordasiewicz et al.
NEURON (2012)
Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway
Dan B. Renner et al.
NEUROSCIENCE LETTERS (2012)
Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation
Anny-Claude Luissint et al.
FLUIDS AND BARRIERS OF THE CNS (2012)
Design and potential application of PEGylated gold nanoparticles with size-dependent permeation through brain microvasculature
Arnold B. Etame et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
Y. Joy Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain
Anja Zensi et al.
JOURNAL OF DRUG TARGETING (2010)
Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases
Reinhard Gabathuler
NEUROBIOLOGY OF DISEASE (2010)
Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones
Anja Zensi et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration
Wim H. De Jong et al.
BIOMATERIALS (2008)
Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles
Ayush Verma et al.
NATURE MATERIALS (2008)
Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery
J Dobson
GENE THERAPY (2006)
Nanogels for oligonucleotide delivery to the brain
SV Vinogradov et al.
BIOCONJUGATE CHEMISTRY (2004)
分享论文
